Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vibe GrowthVIBEF 48 EV-to-EBITDA is 3.45 as of Aug. 06, 2026. GuruFocus rates VIBEF with a GF Score™ of 48/100 and a GF Value™ of $1.31 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 743 Drug Manufacturers companies, Vibe Growth ranks better than 93.27% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Vibe Growth's enterprise value is $1.82 Mil.
Vibe Growth's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $0.53 Mil. Therefore, Vibe Growth's EV-to-EBITDA for today is 3.45.
The historical rank and industry rank for Vibe Growth's EV-to-EBITDA or its related term are showing as below:
VIBEF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -82.26 Med: -0.64 Max: 25.59
Current: 3.54
During the past 13 years, the highest EV-to-EBITDA of Vibe Growth was 25.59. The lowest was -82.26. And the median was -0.64.
VIBEF's EV-to-EBITDA is ranked better than 93.27% of 743
companies
in the Drug Manufacturers industry
Industry Median: 13.06
vs VIBEF: 3.54
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Vibe Growth's PE Ratio (TTM) for today is calculated as:
Vibe Growth's share price for today is $0.39045.
Vibe Growth's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.500.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Vibe Growth's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vibe Growth's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vibe Growth EV-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vibe Growth's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Vibe Growth's EV-to-EBITDA falls into.
Vibe Growth's current Enterprise Value is $1.82 Mil.
Vibe Growth's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.53 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vibe Growth (VIBEF) has a EV-to-EBITDA of 3.45 as of Aug. 06, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Vibe Growth. According to the industry distribution chart, Vibe Growth ranks #50 out of 743 companies in the Drug Manufacturers industry, placing it in the top 6.7%.
Is Vibe Growth's EV-to-EBITDA too high?
Vibe Growth's current EV-to-EBITDA is 3.45. The Drug Manufacturers industry median EV-to-EBITDA is 13.06. Vibe Growth's value of 3.45 is 73.6% below this industry median. Based on the distribution chart, Vibe Growth ranks #50 out of 743 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Vibe Growth has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vibe Growth's EV-to-EBITDA compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Vibe Growth ranks #50 out of 743 companies for EV-to-EBITDA. This places Vibe Growth in the top 7% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 13.06. Vibe Growth's value of 3.45 is 73.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Drug Manufacturers company?
The median EV-to-EBITDA among Drug Manufacturers companies is 13.06, based on 743 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vibe Growth's current EV-to-EBITDA of 3.45 is 73.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Vibe Growth. For the Drug Manufacturers industry, the median EV-to-EBITDA is 13.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vibe Growth's current EV-to-EBITDA is 3.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vibe Growth stock overvalued right now?
Based on GuruFocus' analysis, Vibe Growth (VIBEF) is currently considered Possible Value Trap. The stock's GF Value™ is $1.31, compared to a current price of $0.39 — trading 70.2% below its estimated fair value. The current EV-to-EBITDA is 3.45 and 73.6% below the Drug Manufacturers industry median of 13.06. Vibe Growth's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Vibe Growth (VIBEF), the current EV-to-EBITDA is 3.45 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vibe Growth (VIBEF) Overvalued in 2026?
Based on GuruFocus' analysis, Vibe Growth stock appears to be undervalued.
The current stock price of $0.39 is trading 70.2% below its estimated GF Value™ of $1.31.
GuruFocus considers Vibe Growth to be Possible Value Trap.
Key valuation signals for VIBEF:
EV-to-EBITDA: 3.45
GF Value™: $1.31 vs. price of $0.39 (70.2% below fair value)
Industry Position: 73.6% below the Drug Manufacturers median (#50 of 743)
No single metric tells the full story. See the VIBEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vibe Growth Corp is engaged in the evaluation, acquisition, and development of cannabis cultivation, distribution, and manufacturing assets and retail cannabis dispensaries, predominantly in the U.S., to become a vertically integrated cannabis operator. The company currently operates four dispensaries, one distribution, and one cultivation operation in the State of California, plus one dispensary in Portland, Oregon. It offers cannabis infused products across various categories such as vaporizers, concentrates, edibles, topicals, pre-rolls, etc., and through different brands including Alien Labs, Almora Farm, Buddies, Chill Bud, Highatus, and Others.
48GF Score
Get the complete analysis for VIBEF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VIBEF has been successfully added to your 
